ClinicalTrials.govpublic full text
Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC
non-small cell lung cancer stage iii, borderline resectable carcinoma, neoadjuvant therapy, non-small cell lung cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855577
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.